Jan van Bodegom

Company: Coretag

Job title: Chief Executive Officer

Seminars:

Targeted Alpha Therapy: The Future of Effective Cancer Therapy Using Alpha Emitting Isotopes 1:00 pm

Single alpha-emitting isotopes: how to avoid delayed damage? Ideal half-life: can you combine effectiveness with minimal side effects? Reliable supply: how to secure a strong and reliable supply chainRead more

day: Track B

Necrosis Targeting Radiopharmaceuticals 5:00 pm

Necrosis Targeting Diagnostics to help clinical decision making Necrosis Targeting Alpha and Beta therapy Necrosis Targeting Radiotherapy the path from concept to clinicRead more

day: Day One